Huizhou Dongruncheng Maoyiyouxiangongsi – Trademark Portfolio

Entity Type: 16

Huizhou Dongruncheng Maoyiyouxiangongsi holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 28 (Toys & Sporting Goods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DRCHOER. The owner is based in Huizhou.

Erqi20dongyidanyuan13ceng03haofang

huichengqu, Xurilu1haozhongxinshuianchen

Huizhou 516000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DRCHOER
DRCHOER
Registered 2020

Trademark Classifications

Huizhou Dongruncheng Maoyiyouxiangongsi's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Huizhou Dongruncheng Maoyiyouxiangongsi have?

Huizhou Dongruncheng Maoyiyouxiangongsi has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Huizhou Dongruncheng Maoyiyouxiangongsi file in?

Huizhou Dongruncheng Maoyiyouxiangongsi files trademarks across 1 Nice Classification class. The most active classes are Class 28 (Toys & Sporting Goods). Class 28 covers games and playthings; gymnastic and sporting articles; decorations for christmas trees.

What are Huizhou Dongruncheng Maoyiyouxiangongsi's most well-known trademarks?

Huizhou Dongruncheng Maoyiyouxiangongsi's registered trademark portfolio includes well-known marks such as DRCHOER. These are among 1 currently registered trademark in the portfolio.

What is Huizhou Dongruncheng Maoyiyouxiangongsi's trademark registration success rate?

Huizhou Dongruncheng Maoyiyouxiangongsi has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.